ATE253908T1 - Rhodamin 123 zusammensetzungen für behandlung von prostatakrebs - Google Patents

Rhodamin 123 zusammensetzungen für behandlung von prostatakrebs

Info

Publication number
ATE253908T1
ATE253908T1 AT96305836T AT96305836T ATE253908T1 AT E253908 T1 ATE253908 T1 AT E253908T1 AT 96305836 T AT96305836 T AT 96305836T AT 96305836 T AT96305836 T AT 96305836T AT E253908 T1 ATE253908 T1 AT E253908T1
Authority
AT
Austria
Prior art keywords
treatment
prostate cancer
solution
rhodamine
water
Prior art date
Application number
AT96305836T
Other languages
English (en)
Inventor
John Albert Arcadi
Original Assignee
Huntington Medical Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huntington Medical Res Inst filed Critical Huntington Medical Res Inst
Application granted granted Critical
Publication of ATE253908T1 publication Critical patent/ATE253908T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AT96305836T 1995-08-16 1996-08-08 Rhodamin 123 zusammensetzungen für behandlung von prostatakrebs ATE253908T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51600495A 1995-08-16 1995-08-16

Publications (1)

Publication Number Publication Date
ATE253908T1 true ATE253908T1 (de) 2003-11-15

Family

ID=24053711

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96305836T ATE253908T1 (de) 1995-08-16 1996-08-08 Rhodamin 123 zusammensetzungen für behandlung von prostatakrebs

Country Status (8)

Country Link
US (1) US7008961B1 (de)
EP (1) EP0761216B1 (de)
JP (1) JPH09110724A (de)
AT (1) ATE253908T1 (de)
AU (1) AU6207196A (de)
BR (1) BR9603454A (de)
CA (1) CA2183015A1 (de)
DE (1) DE69630639T2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0029562D0 (en) * 2000-12-04 2001-01-17 Novartis Ag Organic compounds
WO2003020977A2 (en) * 2001-08-31 2003-03-13 The University Court Of The University Of Glasgow Nucleotide repeats assay
WO2006024490A2 (en) * 2004-08-30 2006-03-09 Interstitial Therapeutics Methods and compositions for the treatment of cell proliferation
WO2008115088A1 (fr) * 2007-03-16 2008-09-25 Evgeny Pavlovich Germanov Utilisation de rhodamine 6g en tant que médicament destiné au traitement de néoplasies malignes et d'amyloïdoses
WO2010120203A1 (ru) * 2009-04-14 2010-10-21 ГЕРМАНОВ, Евгений Павлович Применение органических красителей в качестве обезболивающих средств
US11474098B2 (en) 2017-12-22 2022-10-18 The Trustees Of Columbia University In The City Of New York Drug target for preventing pathologic calcium overload in cardiomyocytes and methods of screening for same
CN117677386A (zh) * 2021-07-23 2024-03-08 瓦伦塔有限责任公司 具有亲溶酶体和抗病毒活性的化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260327A (en) * 1985-10-02 1993-11-09 Sloan-Kettering Institute For Cancer Research Methods for inhibiting the proliferation of brain and hepatic metastases by using lonidamine
US5189029A (en) * 1990-04-23 1993-02-23 Bo-Dekk Ventures, Ltd. Indacene compounds and methods for using the same
HUT64224A (en) 1991-08-13 1993-12-28 Dana Farber Cancer Inst Inc Process for the production of the medical preparatives containing rodacimin applicable for treatment of cancer
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease

Also Published As

Publication number Publication date
EP0761216B1 (de) 2003-11-12
BR9603454A (pt) 1998-05-12
AU6207196A (en) 1997-02-20
US7008961B1 (en) 2006-03-07
EP0761216A1 (de) 1997-03-12
JPH09110724A (ja) 1997-04-28
DE69630639D1 (de) 2003-12-18
DE69630639T2 (de) 2004-09-16
MX9603412A (es) 1997-07-31
CA2183015A1 (en) 1997-02-17

Similar Documents

Publication Publication Date Title
DE69215722T2 (de) Verstärker zur Ultraschalltherapie von Erkrankungen sowie diesen enthaltende flüssige Arzneimittelzusammensetzungen
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
ATE232082T1 (de) Prophylaktische und therapeutische behandlung von haupt sensibilisierung und -reizung
BR9715022A (pt) Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada
ES2035259T3 (es) Compuesto absorbente.
NZ292854A (en) Use of an photoactive compound to treat multiple sclerosis which is followed by light therapy
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
DE59600683D1 (de) Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten
DE69630639D1 (de) Rhodamin 123 Zusammensetzungen für Behandlung von Prostatakrebs
ATE421319T1 (de) Mit s-nitrosothiol angereicherte erythrocyten und deren verwendung
DE69825887D1 (de) Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebs
ATE99669T1 (de) N-2,3-butadienyl-tri-aminoalkanderivate.
PT768886E (pt) Efeitos de revestimento endotelial e tratamento de desordens vasospasticas
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
KR900017599A (ko) 종양 치료용 약학 조성물
ATE36333T1 (de) Hydantoin enthaltende therapeutische mittel.
IT1230175B (it) Diffusore di vapori profumati e medicali, realizzato mediante l'uso di elementi costruiti in metallo, preferibilmente inossidabile
KR880000094A (ko) 위염치료제
RU97101420A (ru) Способ лечения тонзиллита
RU94016144A (ru) Средство для лечения больных болезнью рейтера
RU94042570A (ru) Антигипоксическое средство - сок проростков пшеницы
RU94002713A (ru) Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)
ATE224729T1 (de) Verwendung von hyaluronidase
TH61362A (th) องค์ประกอบทางเภสัชกรรม
UA15177C2 (uk) Засіб для лікуваhhя уражеhь слизової травhого тракту

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties